EyePoint Pharmaceuticals所有资讯

丰业银行维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价18美元

富途资讯10/29 19:34

eyepoint pharmaceuticals被查丹资本维持买入评级

道琼斯10/29 19:11

eyepoint pharmaceuticals 分析师评级

Benzinga10/29 19:00

第一资本维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价35美元

富途资讯10/28 23:32

JonesTrading首予EyePoint Pharmaceuticals(EYPT.US)买入评级，目标价45美元

富途资讯10/28 22:32

贝雅维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价38美元

富途资讯10/25 23:34

eyepoint pharmaceuticals的分析师评级

Benzinga10/25 22:02

H.C. Wainwright维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价30美元

富途资讯10/25 18:31

eyepoint pharmaceuticals积极前景：DURAVYU的第3阶段LUGANO试验推动买入评级提升

TipRanks10/25 18:20

第一资本维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价35美元

富途资讯10/25 04:32

Scotiabank开始覆盖eyepoint pharmaceuticals，给予板块表现评级，并宣布目标价为18美元。

Benzinga10/16 22:34

瑞穗证券维持EyePoint Pharmaceuticals(EYPT.US)买入评级

富途资讯10/11 16:31

eyepoint pharmaceuticals (EYPT) 从瑞穗证券获得买入评级

TipRanks10/11 16:09

第一资本维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价35美元

富途资讯09/16 21:32

eyepoint pharmaceuticals 通过 Jefferies 公司宣布股价目标为15.00美元/股

道琼斯08/28 20:32

富瑞集团首予EyePoint Pharmaceuticals(EYPT.US)买入评级，目标价15美元

富途资讯08/28 17:31

在Duravyu有希望的发展中，eyepoint pharmaceuticals的表现优于市场预期。

TipRanks08/16 18:06

eyepoint pharmaceuticals 分析师评级

Benzinga08/13 20:35

JP摩根维持对eyepoint pharmaceuticals的超配评级，将目标价下调至29美元。

Benzinga08/13 20:35

摩根大通维持EyePoint Pharmaceuticals(EYPT.US)买入评级，下调目标价至29美元

富途资讯08/13 20:33